Knudsen Markus Dines, Wang Kai, Wang Liang, Polychronidis Georgios, Berstad Paula, Hjartåker Anette, Fang Zhe, Ogino Shuji, Chan Andrew T, Song Mingyang
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
JAMA Oncol. 2025 Jan 1;11(1):46-54. doi: 10.1001/jamaoncol.2024.5227.
The current recommendation for a 10-year rescreening interval after a negative colonoscopy screening (NCS) result has been questioned, with some studies showing a persistently lower risk of colorectal cancer (CRC) after NCS results.
To examine long-term CRC incidence and mortality after NCS results (ie, no presence of CRC or polyps) and according to a risk score based on major demographic and lifestyle risk factors.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, 3 prospective US population-based cohorts from the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-up Study were followed up from 1988 and 1991 to 2020. Data from the National Health and Nutrition Examination Survey (NHANES) from the January 1, 2017, to December 31, 2018, cycle were used to compare the risk profile distribution with that of the general US population. Data analysis was performed from October 2023 to August 2024.
Time-varying status of NCS results and risk score.
Cox proportional hazards regression was used to calculate hazard ratios (HRs) and 95% CIs for incidence and mortality of CRC.
A total of 195 453 participants (median [IQR] age, 44 [37-56] years at baseline; 81% female) were followed up for a median (IQR) of 12 (6-20) years. Among 81 151 individuals with NCS results and 114 302 without endoscopy, 394 and 2229 CRC cases and 167 and 637 CRC deaths, respectively, were documented. Negative colonoscopy screening results were consistently associated with lower CRC incidence (HR, 0.51; 95% CI, 0.44-0.58) and mortality (HR, 0.56; 95% CI, 0.46-0.70) for 20 years. Among individuals with NCS results, those with an intermediate risk (scores, 6-7) and low risk (scores, 0-5) did not reach the 10-year cumulative incidence of CRC (0.78%) of the high-risk individuals (scores, 8-12) until 16 and 25 years after initial screening, respectively.
These findings provide evidence for shared decision-making between patients and physicians to consider extending the rescreening intervals after an NCS result beyond the currently recommended 10 years, particularly for individuals with a low-risk profile. These results showed, as a proof of concepts, the importance of considering known CRC risk factors when making decisions for colonoscopy rescreening.
结肠镜检查筛查(NCS)结果为阴性后推荐的10年重新筛查间隔受到了质疑,一些研究表明NCS结果后结直肠癌(CRC)风险持续较低。
研究NCS结果(即无CRC或息肉)后以及根据基于主要人口统计学和生活方式风险因素的风险评分的长期CRC发病率和死亡率。
设计、设置和参与者:在这项队列研究中,对来自护士健康研究、护士健康研究II和卫生专业人员随访研究的3个美国前瞻性人群队列从1988年和1991年随访至2020年。使用2017年1月1日至2018年12月31日周期的国家健康和营养检查调查(NHANES)数据,将风险特征分布与美国普通人群进行比较。数据分析于2023年10月至2024年8月进行。
NCS结果和风险评分的随时间变化状态。
使用Cox比例风险回归计算CRC发病率和死亡率的风险比(HRs)及95%置信区间(CIs)。
共对195453名参与者(基线时年龄中位数[四分位间距]为44[37 - 56]岁;81%为女性)进行了中位数(四分位间距)为12(6 - 20)年的随访。在81151名有NCS结果的个体和114302名未进行内镜检查的个体中,分别记录了394例和2229例CRC病例以及167例和637例CRC死亡。阴性结肠镜检查筛查结果在20年内一直与较低的CRC发病率(HR,0.51;95%CI,0.44 - 0.58)和死亡率(HR,0.56;95%CI,0.46 - 0.70)相关。在有NCS结果的个体中,中度风险(评分6 - 7)和低风险(评分0 - 5)的个体直到初次筛查后16年和25年才分别达到高风险个体(评分8 - 12)的10年CRC累积发病率(0.78%)。
这些发现为患者和医生之间的共同决策提供了证据,以考虑将NCS结果后的重新筛查间隔延长至目前推荐的10年以上,特别是对于低风险特征的个体。这些结果作为概念验证,表明在做出结肠镜检查重新筛查决策时考虑已知CRC风险因素的重要性。